<DOC>
	<DOCNO>NCT01077050</DOCNO>
	<brief_summary>The purpose clinical investigation determine safety effectiveness SciBase III device ( Test ) design help distinguish malignant melanoma benign lesion , use electrical impedance spectroscopy ( EIS ) relative histological gold standard ( Reference ) . The purpose study collect data support Pre-market Application ( PMA ) obtain Food Drug Administration ( FDA ) approval market SciBase III Electrical Impedance Spectrometer .</brief_summary>
	<brief_title>SciBase International Melanoma Pivotal Study</brief_title>
	<detailed_description />
	<mesh_term>Melanoma</mesh_term>
	<criteria>Inclusion Criteria For inclusion study , subject fulfill follow criterion : Men woman ethnic group age ≥18 year Primary lesion ( i.e. , metastases recurrent lesion ) physician choose excise . Lesion ≥ 2 mm diameter ≤ 20 mm diameter In subject multiple skin lesion , lesion destine excision must identify purpose study participation . Note : subject may enter study . The subject willing able read , understand sign study specific informed consent form . Subjects exclude study fulfil follow criterion : Skin surface measurable , e.g . lesion stalk Skin surface accessible , e.g . inside ear , nail Lesion locate acral skin , e.g . sole palm . Lesion locate area scar , crust , psoriasis , eczema similar skin condition . Lesion haircovered area , e.g . scalp , beard , moustache whisker . Lesion locate genitalia . Lesion locate area previously biopsied subject kind surgical intervention traumatize . Lesion locate mucosal surface . Skin intact ( measurement area ) e.g . bleed clinical noticeable ulceration . Lesion foreign matter , e.g . tattoo , splinter Lesion and/or reference locate acute sunburn .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2013</verification_date>
</DOC>